Literature DB >> 17109102

Adhesion molecules in chronic ulcerative colitis.

Maya V Gulubova1, Irena M Manolova, Tatyana I Vlaykova, Margarita Prodanova, Jovcho P Jovchev.   

Abstract

BACKGROUND AND AIMS: The adhesion molecule expression in colonic mucosa is pivotal for transition from quiescent to active stage of ulcerative colitis (UC). The aim of the present study is to reveal the adhesion molecule profile of colonic mucosa in the active stage of UC and in remission.
MATERIALS AND METHODS: Biopsy specimens obtained from 14 patients with UC (seven with active disease and seven with UC in remission) and from seven controls were used. Immunohistochemistry was performed with antibodies against ICAM-1, VCAM-1, E-selectin, LFA-1, Mac-1, and VLA-4.
RESULTS: In controls, slight ICAM-1 positivity was observed on thety endothelium of blood vessels of the mucosal and submucosal layer and only single ICAM-1-, Mac-1-, and LFA-1-positive cells were found. In all patients with UC, the endothelium of venules in the edematous mucosal and submucosal layers was ICAM-1-, VCAM-1-, and E-selectin-positive. Numerous ICAM-1- and LFA-1-positive and less VCAM-1-, Mac-1-, and VLA-4-positive inflammatory cells were detected in mucous layers of acute UC. In specimens of UC in remission, the inflammatory cells positive for the studied adhesion molecules were significantly less in number in the mucosa and submucosa (p < 0.05).
CONCLUSIONS: Based on the increased expression of ICAM-1, VCAM-1, and their ligands LFA-1 and VLA-4 in patients with UC, we can conclude that these adhesion molecules play a key role in the adherence of lymphocytes and macrophages to endothelial cells maintaining the chronic inflammation. Presence of E-selectin on endothelial cells of venules could be a sign of relapse after remission in UC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17109102     DOI: 10.1007/s00384-006-0236-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  34 in total

1.  Intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis: presence, visualization, and significance.

Authors:  B Vainer
Journal:  Inflamm Res       Date:  2005-08       Impact factor: 4.575

2.  Elevated serum concentrations of soluble selectin and immunoglobulin type adhesion molecules in patients with inflammatory bowel disease.

Authors:  M Göke; J C Hoffmann; J Evers; H Krüger; M P Manns
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

3.  Criteria of case definition in Crohn's disease and ulcerative colitis.

Authors:  C O'Morain; A Tobin; E Leen; Y Suzuki; T O'Riordan
Journal:  Scand J Gastroenterol Suppl       Date:  1989

4.  A recommended procedure for ultrastructural immunohistochemistry on small human tissue samples.

Authors:  R De Vos; C De Wolf-Peeters; J J van den Oord; V Desmet
Journal:  J Histochem Cytochem       Date:  1985-09       Impact factor: 2.479

5.  Detection of ICAM-1 in experimentally induced colitis of ICAM-1-deficient and wild-type mice: an immunohistochemical study.

Authors:  F Bendjelloul; P Rossmann; P Malý; V Mandys; M Jirkovská; L Prokesová; L Tucková; H Tlaskalová-Hogenová
Journal:  Histochem J       Date:  2000-12

6.  In-situ endothelial cell adhesion molecule expression in ulcerative colitis. E-selectin in-situ expression correlates with clinical, endoscopic and histological activity and outcome.

Authors:  C Cellier; N Patey; G Fromont-Hankard; J P Cervoni; M Leborgne; S Chaussade; J P Barbier; N Brousse
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-12       Impact factor: 2.566

7.  Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease.

Authors:  G Malizia; A Calabrese; M Cottone; M Raimondo; L K Trejdosiewicz; C J Smart; L Oliva; L Pagliaro
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

8.  ICAM-1 and VCAM-1 antisense oligonucleotides attenuate in vivo leucocyte adherence and inflammation in rat inflammatory bowel disease.

Authors:  E Rijcken; C F Krieglstein; C Anthoni; M G Laukoetter; R Mennigen; H U Spiegel; N Senninger; C F Bennett; G Schuermann
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

9.  Adhesion molecules in inflammatory bowel disease.

Authors:  S C Jones; R E Banks; A Haidar; A J Gearing; I K Hemingway; S H Ibbotson; M F Dixon; A T Axon
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

10.  Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease.

Authors:  F Magro; F Araujo; P Pereira; E Meireles; M Diniz-Ribeiro; F Tavarela Velosom
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

View more
  9 in total

1.  Abscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration.

Authors:  Amir J Guri; Raquel Hontecillas; Josep Bassaganya-Riera
Journal:  Clin Nutr       Date:  2010-03-16       Impact factor: 7.324

2.  CD4+CD29+T cells are blamed for the persistent inflammatory response in ulcerative colitis.

Authors:  Yuzhen Zhu; Yanling Feng; Hongbo Liu; Hua Ye; Cancan Guo; Jinshan Feng; Shixue Dai; Xuebao Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Proteomic profiling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the inflammatory colitides.

Authors:  Amosy E M'Koma; Erin H Seeley; Mary K Washington; David A Schwartz; Roberta L Muldoon; Alan J Herline; Paul E Wise; Richard M Caprioli
Journal:  Inflamm Bowel Dis       Date:  2010-08-30       Impact factor: 5.325

4.  Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase.

Authors:  Stephen D Zucker; Megan E Vogel; Tammy L Kindel; Darcey L H Smith; Gila Idelman; Uri Avissar; Ganesh Kakarlapudi; Michelle E Masnovi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-17       Impact factor: 4.052

5.  Expression patterns of angiopoietin-1, -2, and tie-2 receptor in ulcerative colitis support involvement of the angiopoietin/tie pathway in the progression of ulcerative colitis.

Authors:  Ayumi Yoshizaki; Toshiyuki Nakayama; Shinji Naito; Ichiro Sekine
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

6.  Rectal administration of d-alpha tocopherol for active ulcerative colitis: a preliminary report.

Authors:  Seyed-Amir Mirbagheri; Behtash-Ghazi Nezami; Solmaz Assa; Mannan Hajimahmoodi
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

7.  Investigation of the relationship between the Th17/IL-23 pathway and innate-adaptive immune system in TNBS-induced colitis in rats.

Authors:  İhsan Karaboga; Selim Demirtas; Turan Karaca
Journal:  Iran J Basic Med Sci       Date:  2017-08       Impact factor: 2.699

8.  Immunohistochemical Study of Adhesion Molecules in Irritable Bowel Syndrome: A Comparison to Inflammatory Bowel Diseases.

Authors:  Antigony Mitselou; Vasileios Grammeniatis; Anna Varouktsi; Stamatis S Papadatos; Antonios Klaroudas; Konstantinos Katsanos; Vasiliki Galani
Journal:  Adv Biomed Res       Date:  2021-08-30

9.  Contrast Enhanced Ultrasound Molecular Imaging of Spontaneous Chronic Inflammatory Bowel Disease in an Interleukin-2 Receptor α-/- Transgenic Mouse Model Using Targeted Microbubbles.

Authors:  Huaijun Wang; Jose G Vilches-Moure; Thierry Bettinger; Samir Cherkaoui; Amelie Lutz; Ramasamy Paulmurugan
Journal:  Nanomaterials (Basel)       Date:  2022-01-17       Impact factor: 5.076

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.